Phase
Condition
Spinal Cord Injuries
Enuresis
Urinary Incontinence
Treatment
Gentamicin Sulfate
Clinical Study ID
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Provision of signed and dated informed consent form and agreement to complete thedaily dosing log as instructed by the study coordinator.
History of traumatic spinal cord injury (SCI) or non-traumatic spinal cord disease, (SCD) with sustained neurological dysfunction
At least 6 months post-initial hospital discharge following SCI/SCD onset
Neurogenic bladder
Ability to perform daily instillation on self or with help of others and willingnessto adhere to the study regiment.
History of at least 2 documented urinary tract infection (UTI) during the previous 6months (prior to screening)
Have a designated physician or health care provider for routine care
Use of clean intermittent catheterization or catheterization through a stoma (i.e.Mitrofanoff) as their primary method of bladder management
Exclusion
Exclusion Criteria:
Concurrent use of systemic oral or intravesical antibiotic prophylaxis
Documented or self-reported history of gentamicin allergy
Female patients who are currently pregnant or attempting to become pregnant
Patients with a history of 8th cranial nerve disorder
Co-morbidities like cancer and chronic disease that could impact patient safety ORsignificantly affect the rate of UTIs and/or quality of life (QOL) substantially
Urological co-morbidities like bladder cancer and history of kidney disease.
Current UTI at screening (assessed via urine analysis and culture and symptoms)
Concurrent enrollment in a similar clinical trial
Concurrent use of contraindicated diuretics (ethacrynic acid, furosemide)
Current use of other contraindicated or disallowed concomitant medications orreceiving treatments that may influence the results from this study.
Known allergy to aminoglycoside antibiotics; Otological symptoms at baseline (i.e.tinnitus. severe dizziness/vertigo)
At the discretion of study team, individuals who are unable or unlikely to complywith procedures and/or for whom study participation is not recommended (e.g. unableto arrange transportation, cognitive and/or behavioral challenges that precludemeaningful participation, poor health, etc.)
Study Design
Study Description
Connect with a study center
University of Michigan Health System
Ann Arbor, Michigan 48103
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.